Pharmacovigilance case studies
How PVigi helped pharmaceutical companies, biotechs and CROs with QPPV services, literature monitoring, case processing, risk management, audits and market entry.
Local Literature Review for Signal Detection
Systematic local and global literature screening that surfaced potential safety signals early.
Read case study →Regulatory Intelligence Across 25+ Countries
Monthly PV regulatory monitoring for 11 Middle Eastern, 6 North African and 11 European countries.
Read case study →Risk Management Plan for a High-Risk Marketed Product
A tailored RMP that kept a product under regulatory scrutiny on the market.
Read case study →QPPV & LCPPV Services in 25+ Countries
QPPV and local PV contacts appointed in more than 25 countries across Europe, Africa and the Middle East.
Read case study →Benefit-Risk Assessment for a High-Risk Product
A rigorous benefit-risk assessment that regulators accepted, preserving the marketing authorisation.
Read case study →50% Faster Adverse Event Processing
A compliant safety database and streamlined workflow that cut AE processing time by about half.
Read case study →SUSAR and DSUR Submissions for a CRO
On-time SUSAR and DSUR submissions across several global clinical trials.
Read case study →PV Audit Passed With No Critical Findings
Pre-audit assessment, remediation and mock audits ahead of a regulatory PV audit.
Read case study →Market Entry in the Middle East, North Africa and Europe
Regulatory strategy, PV systems and submissions for 25+ markets.
Read case study →Talk to a pharmacovigilance expert
Tell us about your products and markets. We reply within one business day with a clear proposal.
